Uscom Limited · ASX:UCM
Uscom — Investor Presentation (March 2016)
34 slides from Uscom's investor presentation, Mar 17, 2016
Slide 1: Uscom (UCM) – Global Medical Devices and Revenue Growth
March 2016 – Canary Investors Presentation For personal use only Uscom (UCM) – Global Medical Devices and Revenue Growth Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Uscom Executive Chairman/
Slide 2: Disclaimer
Disclaimer For personal use only This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, fina
Slide 3: Uscom
Uscom For personal use only “A rapidly growing Australian medical device company with world leading products and a strategic global corporate vision…” 3 Uscom – Devices the experts use
Slide 4: For personal use only
For personal use only 4
Slide 5: Uscom Recognition
Uscom Recognition For personal use only Company of the Year, 2014 Johnson & Johnson Innovation Industry Excellence Awards “A milestone driven, rapidly growing global medical device company, with real products, real revenue, real growth and an aggressive growth strategy” 5 Uscom – Devices the experts
Slide 6: Business Background
Business Background For personal use only Premium noninvasive cardiovascular and pulmonary monitoring devices Addressing the growing threat of superbugs, heart failure, hypertension and asthma Validated, clinically accepted, cost and life saving devices with critical applications Aggressive global g
Slide 7: Strategic growth
Strategic growth For personal use only Uscom Pulsecor Thor Uscom Limited Limited Kft Limited $50m $50m $50m 2010 2013 2015 2016 Rapidly strengthening balance sheet Acquisitive, strategic and diversified entity Acquired and integrated Pulsecor (2013) and Thor (2015) Debt free acquisitions – scrip, ra
Slide 8: Products and Market
Products and Market For personal use only Multiple high fidelity noninvasive digital medical devices Fluid, Sepsis Hypertension & COPD & Heart Failure Vascular Health & Asthma US 1.3bn market * US 1.7bn market * US 400m market * CAGR of 7.6% * CAGR of 11.5% * CAGR of 6.5% * CE, FDA, TGA, CFDA CE, FD
Slide 9: Products - USCOM 1A
Products - USCOM 1A For personal use only Heart failure, hypertension, sepsis, fluid Non invasive, accurate, compact, platform technology Accurate cardiac output Works with all other hospital equipment Cardiac stroke volume Intuitive touch screen Systemic vascular Real time data resistance Platform
Slide 10: Products - Uscom BP+
Products - Uscom BP+ For personal use only Hypertension, heart failure and vascular disease Central Blood Pressure and Pulse Wave Analysis The new standard for hypertension • FDA, CE Mark, TGA approvals • Home or clinic • Supra-systolic • PPW Analysis Oscollometry • Results in • Reliable and 30 seco
Slide 11: Products - Uscom SpiroSonic
Products - Uscom SpiroSonic For personal use only Asthma, COPD, Occupational Lung Disease and drug compliance High fidelity digital Ultrasonic spirometry • Digital ultrasonic spirometry • Multi-path ultrasonic sensing • FDA, CE, and TGA approvals • Reliable and accurate • Auto calibration • Research
Slide 12: Future - Big Data
Future - Big Data For personal use only Big data needs high quality sensors Uscom specialises in high quality non-invasive sensors • Software analytics • Telemetric signals • Cloud based processing/diagnosis • Personalised clinical advice • Medication and dosage • Serial monitoring • Multiple measur
Slide 13: De-Risked Technology
De-Risked Technology For personal use only Featured in 400+ peer reviewed publications and presentations Sepsis, Heart failure, Hypertension, Fluid management, Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Emergency transport, Anesthesia, Liver transplantation, ICU, Pre-eclampsi
Slide 14: Global
Global 1. Uscom Aus Continued Global Growth 2. 3. Uscom UK Uscom Budapest For personal use only 4. Uscom USA • • •• 2 • •• • • •• • ••• 3 • • • • •• 4 •• •• • • • • • • • • Key Markets •• 1. AsiaPAC – 65% • • • 1 2/3. Europe – 27% 4. Nth America – 8% US Focus FY 2017 Stephen Wilson – Former VP Corpo
Slide 15: New US Products
New US Products For personal use only For launch early FY 2017 15 Uscom – Devices the experts use
Slide 16: US CPT Codes
US CPT Codes For personal use only US Reimbursement Codes for Uscom Technologies Uscom CPT Descriptor Value Products Code (USD) BP+ 93050 Central BP and PWA $17.91 SpiroSonic 94010 Spirometry $36 94060 Pre and post bronchodilator administration, spirometry $61 94375 Respiratory flow volume loop $40
Slide 17: Growth - UCM
Growth - UCM For personal use only A blue sky story with de-risked operations UCM Revenue and Income UCM Distribution Agreements $2,500,000 40 38 $2,039,426 $2,000,000 35 30 27 $1,500,000 $1,377,716 25 $1,010,942 20 $1,000,000 15 12 10 $500,000 5 $0 0 2013 2014 2015 2013 2014 2015 Current revenue on
Slide 18: Growth - UCM
Growth - UCM For personal use only UCM Quarterly Sales Revenue 800,000 700,000 600,000 500,000 $ 400,000 300,000 200,000 100,000 0 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Current revenue only from USCOM 1A 18 BP+ and SpiroSonic revenue in FY 2017
Slide 19: Multi-Products
Multi-Products For personal use only Three product ranges entering profit phase Global Profit Concept Product Pilot Validation Regulatory Revenue Distribution 2016 USCOM 1A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ Uscom BP+ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ±✓ SpiroSonic ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Investment to Profit 26 IP shifting to profit
Slide 20: Revenue Targets
Revenue Targets For personal use only Total Revenue SpiroSonic – FY 2017 20,000,000 18,000,000 16,000,000 BP+ - FY 2017 14,000,000 12,000,000 SpiroSonic $ 10,000,000 BP+ USCOM 8,000,000 USCOM 6,000,000 4,000,000 2,000,000 0 2015 2016* 2017* 2018* 2019* 2020* 20 $20m revenue by 2020 = 5 year CAGR of
Slide 21: The Future
The Future For personal use only Value Cascade Products Sales Operations Opportunities USCOM 1A New appointments Global operations Share price growth Uscom BP+ Current distribution Increased products Dividend BP+Reporter Thor distribution Increased scale Transaction SpiroSonic Completion of New dist
Slide 22: Right Sector - Health
Right Sector - Health For personal use only ASX 10 yr CAGR % pa 14.0 12.1 12.0 10.0 8.0 6.0 UCM sales growth % 4.0 3.5 2014 – 67% 2.0 0.0 0.1 0.0 2015 – 59% S&P 200 Financial NAB Materials BHP RMD Healthcare -2.0 Index (Mining) Index Index -2.4 -4.0 -4.5 -4.3 -6.0 • 1st Feb 2006 – 1st Feb 2016 • Exc
Slide 23: Right Time for Growth
Right Time for Growth For personal use only Revenue Growth % pa 60 50 40 Uscom 30 Resmed % CSL 20 Cochlear 10 0 2013 2014 2015 -10 26 Right company, right time…..
Slide 24: Industry Comparators
Industry Comparators For personal use only Reported and Predicted EBITDA 2 1.5 1 0 UCM ACG ADH -1 -0.7 FY 15 -1.1 -1.1 AUD (m) -2 FY16* -1.81 FY 17* -2.2 -3 -2.76 • Estimate * -4 • Paterson’s, -4 Taylor Collison, -5 BellPotter. -5.15 -6 Code Cap Value Current Target UCM 16m 0.17 0.42 ACG 36m 0.18 0.
Slide 25: Disconnect between performance and price!
ASX:UCM For personal use only Disconnect between performance and price! UCM share price Revenue and Income $3,500,000 $3,100,000 $3,000,000 $2,500,000 $2,039,426 $2,000,000 $1,500,000 $1,377,716 $1,010,942 $1,000,000 $500,000 $0 2013 2014 2015 2016* 9 Investment opportunity….. * Estimate
Slide 26: Research - UCM
Research - UCM For personal use only 5th Oct 2015 5th Oct 2016 12mth Change 0.14c (14m) 0.42c (42m) +200% 12 month Projections and price and cap value targets 9 Ben Kakoschke – 5th October, 2015
Slide 27: Uscom
Uscom For personal use only Value investment ✓ Experienced management ✓ Strong underlying business ✓ Strong growth phase ✓ Invested in growth ✓ Premium global markets ✓ ✓ Diversified and lifesaving technologies✓ Aggressive global growth strategy ✓ ✓ Two new product ranges for market in the next 12mt
Slide 28: Uscom
Uscom For personal use only “Has acquired global assets to ensure reliable revenue growth for investors for the coming decade.” 28 Uscom – Devices the experts use
Slide 29: Thanks
March 2016 – Canary Investors Presentation For personal use only Uscom (UCM) – Global Medical Devices and Revenue Growth Thanks Rob Phillips PhD(med), MPhil(med), FASE, DMU(cardiol) Associate Professor, Critical Care Research Group, School of Medicine, The University of Queensland Executive Chairman
Slide 30: USCOM 1A Competitive Advantage
USCOM 1A Competitive Advantage For personal use only Non- SV beat Method Manufacturer Technology Rel+Rep invasive Simple Cost Portable to beat USCOM 1A Uscom Doppler ✓ ✓ ✓ ✓ ✓ ✓ BioZ Samsung BioImpedance ✗ ✓ ✓ ✗ ✓ ✗ NiCOM Cheetah BioReactance ✗ ✓ ✓ ✗ ✓ ✗ Nexfin Bmeye APP ✗ ✓ ✓ ✓ ✓ ✗ CardioQ Deltex D
Slide 31: Testimonials
Testimonials For personal use only “This machine is saving lives, there are no two ways about it.” Professor Brendan Smith, Anesthetist, Intensivist and Emergency Physician, N.S.W. Dept of Health, Australia “USCOM has changed the way I look at the cardiovascular status of my patients. It’s part of t
Slide 32: BP+ Competitive Advantage
BP+ Competitive Advantage For personal use only Uscom BP+ TensioMed BPLab IEM Centron AtCor Australia Hungary Russia Germany UK Australia USD 3,500 USD 6,000 USD 7,000 USD 7,000 USD 6,300 USD 20,000 1 min 2 min 2 min 2 min 1 min 1 min Stand-alone ABP, needs computer ABP, needs computer ABP, needs co
Slide 33: Why ?
Why ? For personal use only Independent research from Cambridge University, Weill Cornell, University of California, Wales Heart Institute – BP+ = Four stars BP+ is on the international space station 36 McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson AB. Central blood pressure: current e
Slide 34: Thor Competitive Advantage
Thor Competitive Advantage For personal use only Uscom Welch Allyn Schiller Sibelmed Vitalograph MIR Carefusion NDD SpiroSonic Australia USA Switzerland Spain USA Italy USA Switzerland SpiroSonic SpiroPerfect Spirovit SP-1 Dataspir Touch Pneumotrac Spirodoc Microloop EasyOne PLus USD 1,890 USD 2,100